As we gear up to observe World Cancer Day 2026 under the theme 'United by Unique', let's take a look at the stages of ...

Patients with advanced lung cancer who received immunochemotherapy before 15:00 (3 p.m.) had a more delayed disease ...

Johns Hopkins University cancer researcher Mikala Egeblad has received the 2025 Ernst W. Bertner Memorial Award in ...

Prostate cancer (PCa) is one of the most common malignant tumors among men worldwide. Following androgen deprivation therapy ...

A curious phenomenon seen by oncologists, that morning patients do better than those receiving afternoon infusions, gains ...

For patients with hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer, the addition of palbociclib to maintenance anti-HER2 and endocrine ...

Akeega, an oral dual mechanism therapy pairing niraparib with abiraterone, has won a positive committee opinion in Europe for ...

Researchers say cancer's ability to evade treatment and recur is partly due to tumor cells switching between states to ...

One of the most important developments in breast cancer, especially for people with hormone receptor-positive (HR+) advanced ...

Scientists have long observed that cancer patients have a lower risk of Alzheimer’s disease. New research reveals a possible ...